{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:47:49Z","timestamp":1792626469206,"version":"4.5.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/med.0000000000000031","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T12:29:53Z","timestamp":1386246593000},"page":"3-8","source":"Crossref","is-referenced-by-count":107,"title":["Proton pump inhibitor therapy and potential long-term harm"],"prefix":"10.1097","volume":"21","author":[{"given":"Vito Domenico","family":"Corleto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Festa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Di Giulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20211004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000088368","article-title":"Edkins and a century of acid suppression.","volume":"72","author":"Modlin","year":"2005","journal-title":"Digestion"},{"key":"R2-3-20211004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/MOG.0b013e328358e5cc","article-title":"Gastric secretion.","volume":"28","author":"Chu","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11894-010-0141-0","article-title":"Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium.","volume":"12","author":"Ito","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"R4-3-20211004","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s10620-011-1589-y","article-title":"Association between proton pump inhibitor use and anemia: a retrospective cohort study.","volume":"56","author":"Sarzynski","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(98)00087-4","article-title":"Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome.","volume":"104","author":"Termanini","year":"1998","journal-title":"Am J Med"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MJT.0b013e3181f9f6d2","article-title":"Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole.","volume":"19","author":"Ajmera","year":"2012","journal-title":"Am J Ther"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ajg.2011.113","article-title":"Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.","volume":"106","author":"Ngamruengphong","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R8-3-20211004","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bone.2010.12.015","article-title":"Meta-analysis: risk of fractures with acid-suppressing medication.","volume":"48","author":"Kwok","year":"2011","journal-title":"Bone"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1370\/afm.1243","article-title":"Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.","volume":"9","author":"Eom","year":"2011","journal-title":"Ann Fam Med"},{"key":"R10-3-20211004","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.","volume":"124","author":"Yu","year":"2011","journal-title":"Am J Med"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ajg.2012.200","article-title":"The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study corrected from the Canadian Multicentre Osteoporosis Study (CaMos).","volume":"107","author":"Targownik","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-012-2112-9","article-title":"The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study.","volume":"24","author":"Fraser","year":"2013","journal-title":"Osteoporos Int"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01352010","article-title":"Effect of omeprazole, an inhibitor of H,K()-ATPase, on bone resorption in humans.","volume":"53","author":"Mizunashi","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2012.05201.x","article-title":"Systematic review: hypomagnesaemia induced by proton pump inhibition.","volume":"36","author":"Hess","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-120-3-199402010-00006","article-title":"Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12).","volume":"120","author":"Marcuard","year":"1994","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"R16-3-20211004","first-page":"S5","article-title":"Effect of proton pump inhibitors on vitamins and iron.","volume":"104","author":"McColl","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R17-3-20211004","first-page":"4","article-title":"Nutrient malabsorption and fracture risk.","volume":"7","author":"Peura","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events.","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"R19-3-20211004","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH08-12-0808","article-title":"Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.","volume":"101","author":"Sibbing","year":"2009","journal-title":"Thromb Haemost"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease.","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2036.2009.03993.x","article-title":"Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy.","volume":"29","author":"Lahner","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-3-20211004","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","article-title":"Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.","volume":"354","author":"Centanni","year":"2006","journal-title":"N Engl J Med"},{"key":"R23-3-20211004","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression.","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R24-3-20211004","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile associated diarrhea and proton pump inhibitor therapy: a meta-analysis.","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cgh.2011.09.030","article-title":"Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.","volume":"10","author":"Deshpande","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1445-5994.2012.02770.x","article-title":"Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalized patients: a case-controlled study.","volume":"42","author":"Leonard","year":"2012","journal-title":"Intern Med J"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"e50836","DOI":"10.1371\/journal.pone.0050836","article-title":"Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.","volume":"7","author":"Tleyjeh","year":"2012","journal-title":"PLoS One"},{"key":"R29-3-20211004","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","article-title":"Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.","volume":"34","author":"Bavishi","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.","volume":"11","author":"Lo","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2036.2011.04625.x","article-title":"Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.","volume":"33","author":"Choung","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R33-3-20211004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10620-007-9899-9","article-title":"Association between proton pump inhibitor use and spontaneous bacterial peritonitis.","volume":"53","author":"Campbell","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ajg.2009.80","article-title":"Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.","volume":"104","author":"Bajaj","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/apt.12045","article-title":"Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.","volume":"6","author":"Bajaj","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-3-20211004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jgh.12065","article-title":"Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.","volume":"28","author":"Deshpande","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R37-3-20211004","first-page":"811","article-title":"Is microscopic colitis a drug-induced disease J Clin G","volume":"46","author":"Keszthelyi","year":"2012","journal-title":"astroenterol"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.dld.2010.11.015","article-title":"Lansoprazole-induced microscopic colitis: an increasing problem Results of a prospective case-series and systematic review of the literature.","volume":"43","author":"Capurso","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1365-2036.2010.04453.x","article-title":"Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study.","volume":"32","author":"Keszthelyi","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R40-3-20211004","first-page":"411","article-title":"Epidemiological risk factors in microscopic colitis: a prospective case-control study.","volume":"19","author":"Fernandez-Banares","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R41-3-20211004","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11894-008-0100-1","article-title":"Long-term proton pump inhibitor use and gastrointestinal cancer.","volume":"10","author":"Graham","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"R42-3-20211004","first-page":"449","article-title":"Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions Arch Iran M","volume":"16","author":"Eslami","year":"2013","journal-title":"ed"},{"key":"R43-3-20211004","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3748\/wjg.v19.i16.2560","article-title":"Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.","volume":"19","author":"Ahn","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R44-3-20211004","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.1995.tb00391.x","article-title":"Review article: the development of atrophic gastritis: Helicobacter pylori and the effects of acid suppressive therapy.","volume":"9","author":"Kuipers","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"R45-3-20211004","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.","volume":"334","author":"Kuipers","year":"1996","journal-title":"N Engl J Med"},{"key":"R46-3-20211004","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1210\/jc.2007-2279","article-title":"A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.","volume":"93","author":"Berna","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-3-20211004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2012.05106.x","article-title":"Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.","volume":"36","author":"Brunner","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R48-3-20211004","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s10620-010-1493-x","article-title":"Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies.","volume":"56","author":"Zelter","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R49-3-20211004","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1440-1746.2012.07116.x","article-title":"Distribution trends of gastric polyps: an endoscopy database analysis of 24 121 northern Chinese patients.","volume":"27","author":"Cao","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R50-3-20211004","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gut.46.4.464","article-title":"Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.","volume":"46","author":"Bramble","year":"2000","journal-title":"Gut"},{"key":"R51-3-20211004","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(96)90144-0","article-title":"Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results or the MRC randomised controlled surgical trial.","volume":"347","author":"Cuscheri","year":"1996","journal-title":"Lancet"},{"key":"R52-3-20211004","first-page":"1555","article-title":"Does the widespread use of proton pump inhibitors mask, complicate andor delay the diagnosis of Zollinger-Ellison syndrome Aliment Pharmacol T","volume":"15","author":"Corleto","year":"2001","journal-title":"her"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201402000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T06:49:45Z","timestamp":1633502985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201402000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0000000000000031","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}